TRIM63 and melanoma: Consistently, treatment with the MAPK inhibitor U0126 abolished the interaction between ERK and TRIM63, and inhibited TRIM63 phosphorylation in melanoma cells carrying BRAF V600E (Fig. 2O, Q).